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Exposure of implantable venous and electrical de-vices is a relatively common event, mainly caused by inadequate tissue coverage. Bacterial con- tamination and subsequent infection follow exposure. Limited literature is available on exposure manage-ment, with contrasting recommendations, with remov-
al and replacement in a secondary operation several 
months later1,2 often being advocated for pacemakers.
Venous access ports are implanted in cancer pa-
tients for IV chemotherapy delivery, and up to 11% 
of them require removal during treatment due to 
pocket infection or pressure necrosis3; subcutaneous 
electrical devices are also prone to exposure.4 Sec-
ondary replacement of a removed device is respon-
sible for significant patient discomfort, treatment 
delays or interruptions, and direct and indirect costs.Copyright © 2015 The Authors. Published by Wolters Kluwer 
Health, Inc. on behalf of The American Society of Plastic Surgeons. 
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the terms of the Creative Commons Attribution-NonCommercial-
NoDerivatives 3.0 License, where it is permissible to download 
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be changed in any way or used commercially.
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Background: Implantable venous and electrical devices are prone to exposure and infection. Indications 
for management are controversial, but—especially if infected—exposed devices are often removed and 
an additional operation is needed to replace the device, causing a delay in chemotherapy and prolong-
ing healing time. We present our protocol for device salvage, on which limited literature is available.
Methods: Between 2007 and 2013, 17 patients were treated (12 venous access ports, 3 cardiac pacemak-
ers, and 2 subcutaneous neural stimulators). Most patients were operated within 7 days from exposure. 
All patients received only a single perioperative dose of prophylactic antibiotic. In cases of gross infection 
(n = 1), the device was immediately replaced. In the absence of clinical signs of infection:
Complete capsulectomy and aggressive cleaning with an n-acetylcysteine solution and saline solution.
Primary exposure of venous ports with sufficient skin coverage (n = 10): the device was covered 
with local skin flaps.
Recurrent cases, cases with insufficient skin coverage or big devices (n = 7): the device was 
moved to a subpectoral pocket.
Mean follow-up was 19 months.
Results: Sixteen devices were saved. Only one grossly infected pacemaker was removed and replaced immedi-
ately. Only in 1 case, exposure of a venous port recurred after 18 months and was successfully moved to a sub-
pectoral pocket. Chemotherapy was always restarted as scheduled and electrical devices remained functional.
Conclusions: This protocol allows—with a straightforward operation and simple measures—to save 
exposed devices even several days after exposure. Submuscular placement or immediate replace-
ment is indicated only in selected cases. (Plast Reconstr Surg Glob Open 2015;3:e343; doi:10.1097/
GOX.0000000000000303; Published online 30 March 2015.)
Exposed Subcutaneous Implantable Devices: An 
Operative Protocol for Management and Salvage
Francesca Toia, MD




From the Plastic and Reconstructive Surgery, Department 
of Surgical, Oncological and Oral Sciences, University of 
Palermo, Palermo, Italy.
Drs. Toia and D’Arpa contributed equally to this work.
Presented at 25th Annual EURAPS Meeting, May 29–31, 
2014, Ischia, Italy, and the 63rd SICPRE National Meeting 
(Società Italiana di Chirurgia Plastica Ricostruttiva ed Estetica, 
Italian Society of Plastic, Reconstructive and Aesthetic Surgery), 
October 12–15, 2014, Bergamo, Italy.
SICPRE: La SICPRE, Società Italiana di Chirurgia 
Plastica Ricostruttiva ed Estetica, national meeting, 
in Bergamo, Italy on October 12-15, 2014
2014 SICPRE Congress Best Abstracts
Meeting Proceedings 
24
PRS Global Open • 2015
Recently, there is a tendency toward aggressive 
cleaning and salvage of exposed implants in breast 
surgery,5,6 which suggests that a conservative treat-
ment might also be possible for subcutaneous im-
plantable devices. Several authors have suggested 
device salvage and coverage if no gross infection is 
present, but many reports only include small groups, 
and different techniques have been reported.2,7–9
We present our protocol for salvage of exposed 
subcutaneous implantable devices and propose it as a 
tool to speed healing time and avoid treatment delays.
MATERIALS AND METHODS
Between 2007 and 2013, 17 patients with exposed 
devices were treated at a single institution. Among 
exposed devices, there were 12 venous access ports, 3 
cardiac pacemakers, and 2 subcutaneous neural stim-
ulators. Most patients were operated within 7 days 
(range, 2–27). All patients were operated under lo-
cal anesthesia and received only a single preoperative 
dose of cefazoline (2 g) as antibiotic prophylaxis.10
The following protocol was applied to all cases:
•	 Gross infection: removal and immediate re-
placement.
•	 No signs of infection.
A complete capsulectomy was performed for ev-
ery type of device. The device and the surgical field 
were then washed with an n-acetylcysteine solution 
and later irrigated with saline solution (500 ml). 
Then, a different strategy was adopted for venous 
ports and for bigger devices:
Venous ports (primary cases): Primary cases with 
adequate local tissue were covered with random 
flaps, propeller perforator flaps, or perforator-
based flaps. The flap was deepithelialized and 
partially buried under the skin or folded on itself 
to provide additional coverage for the device.
Recurrent cases, big device (cardiac pacemakers, 
neural stimulators) or cases with insufficient 
skin coverage (thin or debilitated patients): The 
device was moved to a subpectoral pocket and 
anchored to the surrounding tissues to avoid dis-
placement and reduce patients’ discomfort.
The wound was closed with buried, monofila-
ment absorbable sutures to minimize risks of bac-
terial colonization. Mean follow-up was 19 months 
(range, 6–50). Data on healing time, postoperative 
infection, recurrent exposure, and other complica-
tions were recorded.
According to Italian rules (art. 13, DLgs n. 
196/03), this study did not require authorization by 
the Institutional Review Board.
RESULTS
There were 11 primary exposures of venous 
ports, 10 of which were maintained in a subcutane-
ous pocket: 4 were covered with a random flap, 2 
with a propeller perforator flap, and 4 with a per-
forator-based flap; only in 1 case of a debilitated 
patient with very thin skin, submuscular placement 
was needed. There were 5 primary exposures of 
electrical devices: a cardiac pacemaker, in the pres-
ence of gross infection, was immediately replaced; 
all 5 devices were moved to a subpectoral pocket. 
One recurrent exposure of a venous access port was 
treated with placement in a subpectoral pocket.
The protocol allowed salvage of all but one de-
vice (16 of 17), which was immediately replaced. 
All patients healed uneventfully within 15 days. No 
patients developed a postoperative infection at a 
minimum follow-up of 6 months. One patient with 
a venous device had a reexposure 18 months after 
coverage. The device was saved again and moved to a 
subpectoral pocket. Submuscular placement caused 
early postoperative discomfort, which solved sponta-
neously within 1 month. Chemotherapy was always 
restarted as scheduled (7–21 days), and electrical de-
vices remained functional.
DISCUSSION
The results of this study show that most devices 
can be saved if treated before gross infection devel-
ops, and only a minority needs removal and imme-
diate replacement. The protocol we propose allows 
salvage of exposed devices in most cases, with a single 
straightforward operation and no risk for patients’ 
health. It avoids the need for secondary reposition-
ing, thus preventing deleterious delays in treatment 
and unnecessary morbidity. Removal and immediate 
replacement is indicated only for grossly infected 
cases and seems effective in controlling infection if 
the above-mentioned measures are adopted.
Literature on salvage of exposed subcutaneous 
devices is limited and mainly concerns pacemak-
ers.2,4,7–9 When a clinical infection is evident, removal 
and delayed replacement is advocated,11,12 although 
some authors suggest immediate replacement for 
exposed devices in the absence of gross infection.7,8
Removal and delayed replacement, which can 
appear as a safer approach, is not devoid of compli-
cations. For venous ports, it delays chemotherapy, pro-
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longs healing, and can impair prognosis, whereas for 
pacemaker, removal of leads from the endocardium 
can lead to acute cardiac problems; also, it requires 
the use of temporary or external pacing device.4
Based on recent trends in breast and orthopedic 
surgery, we propose that a salvage attempt can be 
performed also for these devices.
It is generally agreed that coverage should be as 
early as possible, “within 48 hours of identification of 
exposure when possible,”4 and we recommend treat-
ment even for impeding exposure. However, in our 
series, 3 patients with an exposed venous port were 
referred between 13 and 27 days following exposure, 
and were successfully treated, suggesting that also 
devices with late referral and no clinical sign of in-
fection deserve a salvage attempt.
Several measures may be adopted to salvage ex-
posed devices and minimize risks of infection or 
reexposure. As a small number of pathogens is nec-
essary for developing an infection on an implant, 
complete capsulectomy and accurate cleaning of 
the pocket are mandatory. We routinely irrigate the 
pocket with an n-acetylcysteine solution. n-Acetylcys-
teine is a glutathione precursor, which has shown to 
be effective in destroying bacterial biofilms and in-
hibiting their formation.13,14 Its clinical use is still lim-
ited, but existing experimental and clinical results 
are very promising, also on difficult bacteria as Pseu-
domonas aeruginosa. Following irrigation with n-acet-
ylcysteine, we do recommend a through mechanical 
washing of the pocket with a minimum of 500 ml of 
saline solution, a strategy that has shown to be ef-
fective in the salvage of exposed breast implant.6 As 
for clean-contaminated surgery, a single dose of pre-
operative prophylactic antibiotic was administered.10 
There is contrasting evidence in the literature with 
regard to the need for antibiotic therapy4,8; however, 
it has been shown that even a positive culture in an 
exposed but clinically noninfected device does not 
correlate with reexposure.4 In our series, after irriga-
tion and without postoperative antibiotics, no infec-
tion was observed, despite no use of postoperative 
antibiotics.
Several authors recommend pocket change and 
subpectoral placement,8,9 but there is no general 
agreement and different techniques have been sug-
gested.2,7–9 Bonawitz,4 in their series of 16 patients with 
exposed pacemakers, report no difference in reexpo-
sure rate for submuscular or subfascial placement, the 
latter having become their preferred choice. For pace-
makers or other voluminous electrical devices, we do 
prefer submuscular placement because exposure in 
the absence of infection is often due to an imbalance 
between skin thickness and pressure exerted by the 
device; thus, once the primary cause of exposure is 
not eliminated, reexposure is more likely to happen. 
Also, submuscular placement of the pacemaker allows 
for a more pleasant aesthetic outcome and has been 
proposed as first choice even for primary pacemaker 
placement.15 In our series, subpectoral placement 
was associated with early discomfort and spasm, but 
it always solved within 1 month, as also reported by 
Bonawitz4 and Fayman et al.9
Smaller devices, such as venous ports, can be left 
subcutaneously in most cases. These devices need 
an external access for their use, which is easier in 
case of subcutaneous placement. Thus, submuscu-
lar placement should be limited to selected cases. 
When there is adequate local tissue, the port can be 
moved to a subcutaneous pocket in anatomical con-
tinuity with the previous one. However, skin is often 
thin in cancer patients (often debilitated) with a ve-
nous access port. To obtain thicker skin coverage, a 
local skin flap can be deepithelialized and partially 
buried under the skin overlying the device (Fig. 1) 
or deepithelialized and folded on itself. A random 
or a perforator-based flap can be used in case of 
sufficient skin laxity; a propeller perforator flap is 
preferred when an increased freedom in design and 
movement is required.16
Fig. 1. A, exposed venous access port. A perforator-based flap was planned for reconstruction. B, Following capsulectomy 
and aggressive cleaning of the pocket, the flap was deepithelialized and buried under the skin to provide additional cover-
age. c, one-year postoperative result. the venous access port is still in place.
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Although the numbers are relatively small, they 
are comparable to all the other series previously pub-
lished. Considering that the results of this study are 
promising and that large prospective studies are un-
likely to be performed, we propose the application 
of our protocol for device management in the hope 
that it will be a useful tool for other plastic surgeons 
and that it could ultimately be validated by evalua-
tion on a larger number of patients.
CONCLUSION
The protocol we propose allows—with a straight-
forward operation and simple measures—saving of 
exposed devices even several days after exposure. 
Submuscular placement or immediate replacement 
is indicated only in selected cases. 
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